Reproductive Medicine Institute

Oak Brook, Illinois 60523

Medical Director: Elena Trukhacheva, MD

The Reproductive Medicine Institute in Oak Brook, Illinois, offers a comprehensive range of fertility services under the guidance of Medical Director Dr. Elena Trukhacheva. Whether you're considering IVF, egg freezing for future family planning, or exploring options like donor eggs or surrogacy, their team provides personalized care tailored to your unique journey. With a verified lab accreditation, you can trust that your treatment meets the highest standards of quality and safety.

Understanding success rates can help you make informed decisions about your care. For patients under 35, the clinic reports a live birth rate of 38.40%, while those ages 35-37 see a 30.30% live birth rate. In 2022, they completed 1,436 treatment cycles, reflecting their experience in helping families grow. Starting fertility treatment can feel overwhelming, but having clear information about your options and realistic expectations can help you move forward with confidence. The team at Reproductive Medicine Institute is there to guide you through each step of the process.

Services Offered

IVF

In vitro fertilization — eggs are retrieved and fertilized in a lab, then transferred to the uterus.

Egg Freezing

Oocyte cryopreservation — eggs are retrieved and frozen for future use.

Donor Egg

Uses eggs from a screened donor for patients who cannot use their own.

Surrogacy

Gestational carrier arrangements — an embryo is transferred to a surrogate who carries the pregnancy.

Success Rates

Success rates reflect live births per intended egg retrieval, as reported to the CDC for the 2022 reporting year. Rates vary based on individual patient factors.

Age GroupFresh TransfersFrozen TransfersNat'l Avg
Under 3538.40%-10.036.50%48.4%
35–3730.30%-5.734.10%36%
38–4016.70%-6.927.80%23.6%
Over 405.50%-4.015.70%9.5%

Based on 1,436 total cycles reported. National averages computed across all reporting clinics.

Physicians

Nearby Clinics

Data on this page is sourced from the CDC's National ART Surveillance System (NASS) and the Society for Assisted Reproductive Technology (SART). Success rates reflect live births per intended egg retrieval for the 2022 reporting year. Individual results vary based on patient age, diagnosis, and treatment protocol.